Active	Status	Sponsor type	Region	Phase	Filter
2 Active 14 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Radicava (edaravone) / Mitsubishi Tanabe
NCT06107205: Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects	Completed	1	29	US	TTYP01, Edaravone tablets, Radicava, Edaravone injection, Radicava ORS, Edaravone ORS	Auzone Biological Technology Pty Ltd	Healthy Adult Subjects	12/23	12/23
REFINE-ALS, NCT04259255: Radicava® (Edaravone) Findings in Biomarkers From ALS	Active, not recruiting	N/A	300	Canada, US	Edaravone (Radicava®/Radicava ORS®), Radicava®, Radicava ORS®	Mitsubishi Tanabe Pharma America Inc., Massachusetts General Hospital	Amyotrophic Lateral Sclerosis, ALS	03/24	03/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Radicava (edaravone) / Mitsubishi Tanabe
NCT06107205: Bioequivalence of TTYP01 Tablets in Healthy Adult Subjects	Completed	1	29	US	TTYP01, Edaravone tablets, Radicava, Edaravone injection, Radicava ORS, Edaravone ORS	Auzone Biological Technology Pty Ltd	Healthy Adult Subjects	12/23	12/23
REFINE-ALS, NCT04259255: Radicava® (Edaravone) Findings in Biomarkers From ALS	Active, not recruiting	N/A	300	Canada, US	Edaravone (Radicava®/Radicava ORS®), Radicava®, Radicava ORS®	Mitsubishi Tanabe Pharma America Inc., Massachusetts General Hospital	Amyotrophic Lateral Sclerosis, ALS	03/24	03/24